People: Ligand Pharmaceuticals Inc (LGND.O)
18 Aug 2017
Dr. Stephen L. Sabba, M.D. is Independent Director of the Company. He has been a leading Bio/Pharma Analyst and Fund Manager for Knott Partners, L.P., an investment fund company, since November 2006. Previously he was a Partner and Director of Research with Kilkenny Capital Management, a Chicago-based biomedical hedge fund. Prior to that, Dr. Sabba was Director of Research at Sturza’s Medical Research, and previously was a gastroenterologist and internist in private practice at Phelps Memorial Hospital in North Tarrytown, New York. He received his medical degree from the New York University School of Medicine, and completed a residency in internal medicine and a fellowship in gastroenterology at the Veterans Administration Medical Center in New York City. He earned a Bachelor of Science degree with honors at Cornell University. Dr. Sabba has served as a member of the board of the directors for QLT, Inc., a leading Canadian biotech company, since June 2012.
|Total Annual Compensation, USD||--|
|Restricted Stock Awards, USD||74,205|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||210,701|
|Fiscal Year Total, USD||284,906|